TRIFECTAR Trademark

Trademark Overview

On Friday, February 14, 2020, a trademark application was filed for TRIFECTAR with the United States Patent and Trademark Office. The USPTO has given the TRIFECTAR trademark a serial number of 88797902. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, January 31, 2022. This trademark is owned by PACT Pharma, Inc.. The TRIFECTAR trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Drug discovery services; Research and development of manufacturing processes for novel cell therapies in the pharmaceutical and biotechnology fields; Research and development of manufacturing technology in the field of cell therapies and personalized cell therapies; Pharmaceutical research and development in the field of manufacturing processes for novel cell therapies
trifectar

General Information

Serial Number88797902
Word MarkTRIFECTAR
Filing DateFriday, February 14, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, January 31, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 15, 2020

Trademark Statements

Goods and ServicesConsulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Drug discovery services; Research and development of manufacturing processes for novel cell therapies in the pharmaceutical and biotechnology fields; Research and development of manufacturing technology in the field of cell therapies and personalized cell therapies; Pharmaceutical research and development in the field of manufacturing processes for novel cell therapies
Pseudo MarkTRIFECTA

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 21, 2020
Primary Code042
First Use Anywhere DateTuesday, September 1, 2020
First Use In Commerce DateTuesday, September 1, 2020

Trademark Owner History

Party NamePACT Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NamePACT Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Monday, January 31, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, January 31, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, July 8, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 8, 2021NON-FINAL ACTION E-MAILED
Thursday, July 8, 2021SU - NON-FINAL ACTION - WRITTEN
Monday, June 14, 2021STATEMENT OF USE PROCESSING COMPLETE
Thursday, June 3, 2021USE AMENDMENT FILED
Monday, June 14, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 3, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, June 1, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 21, 2021CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, April 20, 2021ASSIGNED TO PETITION STAFF
Sunday, January 24, 2021EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Friday, January 8, 2021TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, September 23, 2020EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, September 15, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 15, 2020PUBLISHED FOR OPPOSITION
Wednesday, August 26, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 11, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 21, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 21, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 16, 2020ASSIGNED TO LIE
Friday, July 3, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 12, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 12, 2020NON-FINAL ACTION E-MAILED
Tuesday, May 12, 2020NON-FINAL ACTION WRITTEN
Tuesday, May 5, 2020ASSIGNED TO EXAMINER
Friday, February 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 18, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

trifectar therapies cell research development pharmaceutical manufacturing services novel fields field